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Abstract This study describes evidence for the absorption of 
flavonoids and their presence in human plasma in the glycosy-
lated form by HPLC analysis with photodiode array detection. 
Rutin and other quercetin glycosides, phloridzin, as well as an 
anthocyanin are detected simultaneously. In addition, a com-
pound eluting with the spectral properties of the aurone family is 
identified. The results reveal that phloretin and quercetin are 
absorbed from the diet as glycosides. The polyphenols are 
detected in plasma from non-supplemented humans at individual 
levels in the range 0.5-1.6 n.M. 
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1. Introduction 
The protective effects of diets rich in fruit and vegetables 
against cardiovascular disease and certain cancers [1-3] have 
been attributed partly to the antioxidant vitamins and caro-
tenoids contained therein [3]. Recent work is beginning to 
highlight the potential role of the phenolic components of 
fruit, vegetables, beverages and grains, the flavonoids, phenyl-
propanoids and phenolic acids which may act as antioxidants, 
or indeed, in combination with other constituents such as 
glucosinolates, Índoles, dithiolthiones, isothiocyanates, etc, 
as agents of alternative mechanisms that may contribute to 
the anticarcinogenic or cardioprotective actions. 
Many in vitro studies demonstrate the free radical scaveng-
ing properties of dietary phenolic phytochemicals [4-9]. In-
deed, the antioxidant activities of the flavonoids are, in 
many cases, higher than those of vitamins C and E on a molar 
basis [6,7]. This is attributed to the redox properties of the 
phenolic hydroxyl groups, their number and chemical rela-
tionships [4]. Many flavonoids occur in foods in the glycosidic 
form and while substitution of phenolic groups decreases the 
antioxidant activity, in many cases it is still elevated in com-
parison with vitamin C. 
There is little information concerning the extent to which 
the polyphenolics are absorbed in humans, their metabolism, 
pharmaco-kinetics and bioavailability. Although a small num-
ber of investigations have provided evidence for uptake of 
specific flavonoids in rats [10-15], few studies have demon-
strated flavonoid uptake in humans in vivo. Furthermore, it 
is not clear whether the aglycone or the glycoside is absorbed, 
nor has a method been applied which can identify more than 
one family simultaneously in any particular plasma sample. 
The study presented here describes a method for identifying 
and quantifying flavonoids in plasma from human subjects 
applying HPLC analysis with photodiode array detection. 
The preparative approach to the plasma extraction, the sol-
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vent system, column and detection conditions described al-
lows detection of glycosides of flavonol, flavone and dihydro-
chalcone families. Members of the aurone and anthocyanidin 
families are also detected but not characterised. The system 
provides evidence for the absorption of the polyphenols as 
individual glycosides at levels of detection down to approx. 
400-600 nM in human plasma. 
2. Materials and methods 
2.1. Chemicals 
Methanol and acetonitrile, all HPLC grade, were obtained from 
Rathbum Limited, Walkerburn, UK. All phenolics were obtained 
from Extrasynthese, ZI Lyon Nord, Genay, France. Elgastat UHP 
double-distilled water (18+Q grade) was used in all experiments. 
2.2. Preparation of plasma extract 
Fresh venous blood was taken by venipuncture, from normal in-
dividuals on non-supplemented diets, into acid-citrate-dextrose as an-
ticoagulant at a 1:5 dilution. The blood was immediately centrifuged 
at 800 Xg (and 4°C) and the plasma separated from the packed ery-
throcytes and buffy coat. Plasma (1 ml volume) was transferred to a 
tube containing salicylic acid as internal standard (at final diluted 
concentration of 10 ug/ml) and the sample was deproteinised by add-
ing 4 vols. of methanol. After standing for 5-10 min, the tubes were 
vortexed and centrifuged at 800Xg (at 4°C). The supernatant was 
collected and the methanol removed by rotary evaporation under 
vacuum at 40°C. The resultant aqueous fraction was filtered using a 
Flowpore 0.22 am sterile non-pyrogenic membrane filter directly into 
an HPLC vial and analysed directly. 
2.3. Determination of polyphenols in plasma 
The HPLC system used consisted of an autosampler with Peltier 
temperature controller, a Photodiode Array Detector and the Soft-
ware system which controlled all the equipment and carried out data 
processing. A Nova-Pak C18 column (4.6x250 mm) with a 4 um 
particle size was used and the temperature maintained by the column 
oven set at 30°C. Injection was by means of an autosampler, with a 
100 ul fixed loop and the volume injected was 30 ul. Elution (0.5 ml/ 
min) was performed using a solvent system comprising solvent A (20% 
methanol in 0.1% hydrochloric acid) and acetonitrile mixed using a 
linear gradient held at 95% solvent A for 10 min and then decreasing 
linearly to 50% solvent A at 50 min, back to 95% solvent A at 55 min 
and held at these conditions for a further 5 min. There was a 10 min 
delay before the next injection to ensure re-equilibration of the col-
umn. The chromatograms were obtained according to the retention 
time of each fraction with detection at both 280 and 350 nm. Peak 
identification of each component was effected post-run using spectro-
scopic analysis by photodiode array detection from 200 to 600 nm. 
2.4. Preparation of standards 
Stock solutions of a large range of standards were prepared by 
dissolving 0.6-1.2 mg of sample into 1 ml of methanol. Solutions 
were stored at 0-4°C and used within 4 weeks from the date of prep-
aration, after spectroscopic monitoring, except for the anthocyanidins 
which were prepared freshly. 
Stock solutions were diluted 1:10 in methanol, followed by dilution 
of aliquots of 10, 15 and 20 JJ.1 into 1 ml of water. This was taken 
through the same extraction procedure as the plasma samples after 
incorporation of 10 |ig internal standard. The standard curves for the 
rutin (quercetin 3-rutinoside), quercetin 3-glucoside, quercetin 4'-glu-
coside and phloridzin (phloretin 2'-glucoside) are shown in Fig. 1. 
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Fig. 1. Standard curves for phloridzin, rutin, quercetin 4'-0-glucoside, quercetin 3-glucoside. The response unit on the y-axis represents the ra-
tio of peak area of sample to peak area of internal standard. 
2.5. The recovery offlavonol glucosides from plasma 
For recovery experiments, rutin, quercetin 3-glucoside, quercetin 4'-
O-glucoside and phloridzin were diluted into 1 ml of water (control) 
or plasma, with salicylic acid at final concentrations of 0.6, 1.05, 1.2, 
0.61 and 10 ug/ml, respectively. The samples were deproteinised and 
prepared for HPLC analysis as described above. Recoveries were in 
the range 90-100%. 
3. Results 
Fig. 2 shows the chromatograms of flavonoids from repre-
sentative plasmas from normal healthy individuals (VLM/24 
and LCB/1), with UV detection at 280 and 350 nm, respec-
tively. The polyphenols are identified from their retention 
times relative to the internal standard. The glycosides have 
shorter retention times than their corresponding aglycones 
due to their higher polarities, and thus, in comparison with 
the range of standards applied, it is possible to distinguish 
them. Linking together the retention times with the spectral 
profiles of the individual peaks from the chromatograms (Fig. 
3), the specific individual polyphenols identified are rutin, 
phloridzin and other quercetin glycosides with retention times 
and concentrations in plasma as shown in Table 1. Spiking 
plasma with individual compounds further confirmed the 
identification of phloridzin and rutin but the quercetin gluco-
sides were not the 3- or 4'-derivative. The typical profile of an 
aurone (specific characteristic, the peak in the 421 nm region), 
and an anthocyanin (main visible peak at 526 nm) were also 
detected but not yet identified. 
4. Discussion 
This study describes an HPLC method for photodiode ar-
ray detection of several specific families of dietary flavonoids 
in human plasma in one run including flavonol or flavone 
glycosides, dihydrochalcone, aurone and anthocyanidin fam-
ilies. The identification and quantification as phloridzin and 
rutin indicates their absorption as glycosides. Few previous 
studies have achieved such detection. Little is known about 
the bioavailability, absorption and metabolism of polyphenols 
in humans and it is likely that different groups of flavonoids 
have different pharmacokinetic properties. Absorption of diet-
ary quercetin in healthy ileostomy volunteers has been con-
cluded from studies defining absorption of quercetin as oral 
intake minus ileostomy excretion [16]. Three volunteers re-
ceived quercetin-glucoside-rich fried onions equivalent to 89 
mg aglycone, pure rutin equivalent to 100 mg aglycone, or 100 
mg pure quercetin, from which absorption according to their 
above definition, was defined as 52, 17 and 24%, respectively. 
The same group also studied the time course of plasma quer-
cetin concentration in two subjects after ingestión of fried 
onions containing quercetin glycosides to the level of querce-
tin aglycone equivalent to 64 mg [17]. Quercetin was deter-
mined after extraction with simultaneous hydrolysis so the 
question of absorption as the glycoside or aglycone was not 
addressed. Fluorescence detection at 485 nm emission re-
vealed quercetin as an aluminium-quercetin complex after 
post-column derivatisation with aluminium nitrate. Peak plas-
ma levels of 196 ng/ml total quercetin were detected. Manach 
et al. [18] have studied the absorption of quercetin in rats. 
Quercetin conjugated with isorhamnetin was recovered in 
the plasma of rats fed a quercetin diet, but curiously the 
conjugated complex was reported to be bound to albumin. 
The pharmacokinetics and metabolism of a single oral sup-
plement of diosmin (the 7-rhamnoglucoside of diometin, 
5,7,3'-trihydroxy-4'-methoxy flavone) in human volunteers 
were studied by Cova et al. [19] arising from its attributed 
properties of vascular protection [20]. Diosmetin was detected 
by liquid chromatography-mass spectrometry at peak levels of 
400 ng/ml in plasma after 1 h, decreasing to 50 ng/ml at 48 h. 
Evidence exists that catechin is absorbed by the human gut 
[21] and other investigations [22] involving oral administration 
of 3-0-methyl-(+)-[U-14C]catechin (three volunteers) detected 
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Fig. 2. HPLC chromatograms of two representative plasma samples (volunteers VLM/24 and LCB/1) depicting the retention times on UV de-
tection at 280 and 350 |xm, respectively, and absorption intensities (conditions described in Section 2). 
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Fig. 3. Spectral profiles of selected individual polyphenolic components as they elute from the column: (a) rutin, (b) quercetin glucoside, 
(c) phloridzin, (d) anthocyanidin, (e) aurone. 
and measured the supplement in the plasma by HPLC with 
UV detection at 280 nm. Peak levels of 11-18 |J.g/ml were 
found within 2 h of administration. Radioactivity also peaked 
with the same time scale at concentrations between 48 and 60 
ug equivalents/ml plasma. 
The study reported here describes a simple method for the 
simultaneous detection in one run of several of families of 
flavonoids in plasma of non-supplemented normal healthy hu-
man subjects. Individual levels down to approx. 0.6 ixM are 
detected by HPLC with photodiode array detection. The up-
take of flavonoids in the glycosylated form is demonstrated. 
In addition, constituents identified, from their spectroscopic 
properties [23] and their range of retention times, as the an-
thocyanidin, aurone and other members of the flavone glyco-
side families are indicated, although precise identification and 
quantification remain to be resolved. 
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Table 1 
Retention times of flavonoid peaks and concentrations (|iM) of identified substances in plasma sample VLM/24 with detection at 280 nm and 
plasma sample LCB/1 with detection at 350 nm 
Retention time Family Component identification Concentration (|iM) 
Sample VLM/24 (280 
24.91 
26.38 
27.91 
29.44 
30.38 
33.44-42.91 
45.31 
Sample LCB/1 
24.57 
25.17 
26.17 
27.71 
28.24 
29.24 
30.57 
32.51 
nm detection) 
(350 nm detection) 
flavonol 
NI 
flavonol 
dihydrochalcone 
internal standard (IS) 
4 peaks 
aurones 
flavonol 
flavonol 
flavonol 
flavonol 
flavonol 
dihydrochalcone 
internal standard 
anthocyanin 
(IS) 
rutin 
NI 
quercetin glycoside (not rutinoside) 
phloridzin 
salicylic acid 
NI 
rutin 
quercetin glycoside (not rutinoside) 
quercetin glycoside (not rutinoside) 
quercetin glycoside (not rutinoside) 
quercetin glycoside (not rutinoside) 
phloridzin 
salicylic acid 
NI 
0.72 
NQ 
0.60a 
0.66 
NQ 
0.76 
0.40" 
0.81a 
1.26a 
1.34a 
1.64 
NQ 
NI, not identified; NQ, not quantified. HPLC conditions in Section 2. 
"Indicates concentration calculated with reference to the standard to quercetin 3-glucoside. 
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